Blood test to measure immunotherapy levels in gynecological cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how well a special blood test can detect certain immunotherapy drugs in your body. By measuring these drugs, doctors hope to better understand how the treatment is working for gynecological cancers and personalize care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of a gynecological cancer (such as ovarian, uterine, or cervical cancer).
- You must be currently receiving or scheduled to receive immunotherapy as part of your cancer treatment.
- You must be 18 years of age or older.
- You must be willing and able to provide written informed consent to participate.
- You must have biological samples (such as blood or other bodily fluids) available for testing.
- You cannot have received prior monoclonal antibody therapy that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special blood test to look for tumor DNA in your blood to monitor for cervical cancer recurrence and help guide treatment decisions. It may help your doctor know if your cancer is coming back and choose the best treatment options.
This study looks at how gut bacteria may relate to how well immunotherapy works in people with advanced or returning gynecologic cancer. You may be asked to give stool samples several times so researchers can measure changes in your gut microbiome.
This study looks at how well immunotherapy works for advanced or recurrent endometrial and cervical cancer by checking certain markers in your blood and tissue. It aims to find out which patients might benefit most from this treatment.
This study looks at blood samples from people with blood cancers to find markers that might predict how well immunotherapy will work. The goal is to help doctors choose the right treatment for each person.
This trial is testing a simple blood test (using white blood cells) to see if it can predict how well immunotherapy will work for people with advanced cancer. If you are starting immunotherapy soon as your first treatment, this study might help guide your care.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
Hear when a new Gynecological Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.